sumatriptan has been researched along with l 772405 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer, MS; Castro, JL; Guiblin, AR; Jelley, RA; Matassa, VG; Russell, MG; Stanton, JA; Sternfeld, F; Street, LJ | 1 |
| Beer, MS; Broughton, HB; Castro, JL; Hitzel, L; Matassa, VG; Pengilley, RR; Russell, MG; Sohal, B; Stanton, JA; van Niel, MB; Watt, AP | 1 |
| Arora, J; Demschyshyn, L; Draper, S; Edwards, L; Harrison, S; Isaac, M; Labrie, P; MacLean, N; Maddaford, S; Naismith, A; O'Brien, A; Papac, D; Slassi, M; Tehim, A; Wang, H; Wilson, J; Xin, T | 1 |
3 other study(ies) available for sumatriptan and l 772405
| Article | Year |
|---|---|
3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.
Topics: Humans; Piperidines; Protein Binding; Pyrrolidines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists | 1997 |
3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.
Topics: Animals; Biological Availability; CHO Cells; Computer Simulation; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Male; Models, Molecular; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Structure-Activity Relationship; Transfection; Triazoles | 1999 |
Design, synthesis and biological activity of novel dimethyl-[2-[6-substituted-indol-1-yl]-ethyl]-amine as potent, selective, and orally-bioavailable 5-HT(1D) agonists.
Topics: Administration, Oral; Amines; Binding Sites; Biological Availability; Drug Design; Humans; Indoles; Kinetics; Molecular Conformation; Receptor, Serotonin, 5-HT1B; Serotonin Receptor Agonists; Structure-Activity Relationship | 2003 |